Author Question: Schools do not have to conduct FBAs of students with disabilities when considering a change in ... (Read 46 times)

Themember4

  • Hero Member
  • *****
  • Posts: 538
Schools do not have to conduct FBAs of students with disabilities when considering a change in educational placement, including suspension and expulsion.
 
  Indicate whether the statement is true or false

Question 2

What is the most appropriate step to take if a behavior intervention plan isn't working?
 
  a. schedule an IEP Team meeting to consider a change in placement
  b. conduct a manifestation determination assessment
  c. assess the student's academic skills
  d. place the student in an interim alternative educational setting
  e. change the plan



tranoy

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

False

Answer to Question 2

E



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Anti-aging claims should not ever be believed. There is no supplement, medication, or any other substance that has been proven to slow or stop the aging process.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library